Home/Filings/4/0000897069-25-000134
4//SEC Filing

Ng George K 4

Accession 0000897069-25-000134

CIK 0001533743other

Filed

Jan 28, 7:00 PM ET

Accepted

Jan 29, 5:05 PM ET

Size

5.3 KB

Accession

0000897069-25-000134

Insider Transaction Report

Form 4
Period: 2025-01-27
Ng George K
DirectorChief Executive Officer
Transactions
  • Purchase

    Common Stock

    2025-01-27$0.80/sh+87,200$69,54287,200 total(indirect: George Ng IRRA FBO: George Ng)
Holdings
  • Common Stock

    (indirect: By Trust)
    20,000

Documents

1 file

Issuer

Processa Pharmaceuticals, Inc.

CIK 0001533743

Entity typeother

Related Parties

1
  • filerCIK 0001638744

Filing Metadata

Form type
4
Filed
Jan 28, 7:00 PM ET
Accepted
Jan 29, 5:05 PM ET
Size
5.3 KB